Oscillating field stimulation in the treatment of spinal cord injury

PM and R

Volumn 2, Issue 12 SUPPL, 2010, Pages

  Walters, Beverly C ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRODE; ELECTROSTIMULATION THERAPY; HUMAN; METHODOLOGY; MOTOR PERFORMANCE; PARAPLEGIA; PHYSIOLOGY; REVIEW; SPINAL CORD INJURY; TREATMENT OUTCOME; WOUND HEALING;

ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; HUMANS; MOTOR SKILLS; PARAPLEGIA; SPINAL CORD INJURIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 79952279670     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.10.014     Document Type: Article

References (28)

1. Bracken MB, Collins WF, Freeman DF, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984;261:45-52.
2. Bracken MB, Shepard MJ, Hellenbrand KG, et al. Methylprednisolone and neurological function 1 year after spinal cord injury. J Neurosurg 1985;63:704-713.
3. Bracken MB, Shepard MJ, Collins WF, et al. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 1990;322:1405-1411.
4. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours of tirilasad mesylate for 48 hours in the treatment of acute spinal cord injury. JAMA 1997;277:1597-1604.
5. Geisler FH, Coleman WP, Grieco G, et al. Recruitment and early treatment in a multicenter study of acute spinal cord injury. Spine 2001;2:558-567.
6. Geisler FH, Dorsey FC, Coleman WP. GM-1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis. Acta Neurobiol Exp 1990;50:515-521.
7. Geisler FH, Dorsey FC, Coleman WP. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury. Ann Emerg Med 1993;22:1041-1047.
8. Coleman WP, Benzel D, Cahill DW, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Dis 2000;13: 185-199.
9. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. Can Med Assoc J 2003;168:1145-1146.
10. Wallace MC, Tator CH, Gentles WM. Effect of alternating current stimulation of the spinal cord on recovery from acute spinal cord injury in rats. Surg Neurol 1987;28:269-276.
11. Fehlings MG, Tator CH, Linden RD. The effect of direct-current field on recovery from experimental spinal cord injury. J Neurosurg 1988;68: 781-792.
12. Borgens RB, Blight AR, Murphy DJ. Axonal regeneration in spinal cord injury: a perspective and new technique. J Comp Neurol 1986;250: 157-167.
13. Borgens RB, Blight AR, Murphy DJ, Stewart L. Transected dorsal column axons within the guinea pig spinal cord regenerate in the presence of an applied electric field. J Comp Neurol 1986;250:168- 180.
14. Borgens RB, Blight AR, McGinnis ME. Functional recovery after spinal cord hemisection in guinea pigs: the effects of applied electric fields. J Comp Neurol 1990;296:634-653.
15. Borgens RB, Bohnert DM. The responses of mammalian spinal axons to an applied DC voltage gradient. Exp Neurol 1997;145:376-389.
16. Borgens R. Electrically mediated regeneration and guidance of adult mammalian spinal axons into polymeric channels. Neuroscience 1999; 91:251-264.
17. Borgens RB, Toombs JP, Blight AR, et al. Effects of applied electric fields on clinical cases of complete paraplegia in dogs. Restor Neurol Neurosci 1993;5:305-322.
18. Borgens RB, Toombs JP, Breur G, et al. An imposed oscillating electrical field improves the recovery of function in neurologicically complete paraplegic dogs. J Neurotrauma 1999;16:639-657.
19. Shapiro S, Borgens R, Pascuzzi R, et al. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. J Neurosurg Spine 2005;2:3-10.
20. Priebe MM, Waring WP. The interobserver reliability of the revised American Spinal Injury Association standards for neruological classification of spinal injury patients. Am J Phys Med Rehabil 1991;70: 268-270.
21. Shapiro S. Erratum. J Neurosurg Spine 2008;8:604.
22. Tator C. Phase 1 trial of oscillating field stimulation for complete spinal cord injury in humans. J Neurosurg Spine 2005;2:2.
23. Cyberkinetics Neurotechnology Systems Inc. SEC Filing SB-2/A 7-23- 07. Available at: http://www.sec.gov/Archives/edgar/data/1180253/ 000114420407037653/v081531_sb2a1.htm. Accessed October 27, 2010.
24. Fawcett JW, Curt A, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007;45:190-205.
25. Steeves JD, Lammertse D, Curt A, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007;45:206-221.
26. Tuszynski MH, Steeves JD, Fawcett JW, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 2007;45:222-231.
27. Lammertse D, Tuszynski MH, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord 2007;45:232-242.
28. Anderson K. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 2007;21:1371-1383.